Home NDC 53808-1100 AMLODIPINE BESYLATE
Product NDC 53808-1100
11-digit product format 538081100
Labeler code 53808
Product ID 53808-1100_3019dfa7-fda7-4049-adfc-4224d14ded5d
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name AMLODIPINE BESYLATE
Dosage form TABLET
Route ORAL
Labeler DOH CENTRAL PHARMACY
Application ANDA078552
Marketing category ANDA
Marketing start 2018-01-23
Marketing end 0000-00-00
Substance AMLODIPINE BESYLATE
Active strength 5 mg/1
Pharmacologic classes Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS]
NDC exclude flag No
Listing certified through 2020-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 30 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 53808-1100-1 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 53808-1100-1 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 53808-1100-1 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 53808-1100-1 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 53808-1100-1 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 53808-1100-1 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 53808-1100-1 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 53808-1100-1 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 53808-1100-1 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 53808-1100-1 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 53808-1100-1 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 53808-1100-1 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 53808-1100-1 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 53808-1100-1 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 53808-1100-1 1332a3947898…d4bfe170f9cd…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A078552-001 AMLODIPINE BESYLATE AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2009-04-08 A078552-002 AMLODIPINE BESYLATE AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2009-04-08 A078552-003 AMLODIPINE BESYLATE AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2009-04-08
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 126 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A078552-001 AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2009-04-08 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A078552-002 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2009-04-08 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A078552-003 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2009-04-08 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A078552-001 AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2009-04-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A078552-002 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2009-04-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A078552-003 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2009-04-08 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A078552-001 AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2009-04-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A078552-002 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2009-04-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A078552-003 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2009-04-08 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A078552-001 AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2009-04-08 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A078552-002 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2009-04-08 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A078552-003 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2009-04-08 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A078552-001 AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2009-04-08 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A078552-002 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2009-04-08 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A078552-003 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2009-04-08 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A078552-001 AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2009-04-08 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A078552-002 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2009-04-08 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A078552-003 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2009-04-08 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A078552-001 AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2009-04-08 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A078552-002 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2009-04-08 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A078552-003 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2009-04-08 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A078552-001 AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2009-04-08 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A078552-002 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2009-04-08 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A078552-003 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2009-04-08 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A078552-001 AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2009-04-08 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A078552-002 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2009-04-08 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A078552-003 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2009-04-08 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A078552-001 AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2009-04-08 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A078552-002 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2009-04-08 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A078552-003 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2009-04-08 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A078552-001 AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2009-04-08 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A078552-002 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2009-04-08 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A078552-003 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2009-04-08 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A078552-001 AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2009-04-08 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A078552-002 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2009-04-08 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A078552-003 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2009-04-08 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A078552-001 AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2009-04-08 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A078552-002 AMLODIPINE BESYLATE EQ 5MG BASE TABLET / ORAL AB 2009-04-08 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A078552-003 AMLODIPINE BESYLATE EQ 10MG BASE TABLET / ORAL AB 2009-04-08 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A078552-001 AMLODIPINE BESYLATE EQ 2.5MG BASE TABLET / ORAL AB 2009-04-08 1e350fbaab3a…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 126 observed states.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 53808-1100-1 AMLODIPINE BESYLATE 30 in 1 BLISTER PACK TABLET 30 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 53808-1100 AMLODIPINE BESYLATE TABLET [DOH CENTRAL PHARMACY] 1 Legacy NDC, 1 package rows 20190116_c411a30f-51be-490d-9bc3-d5cbe1357c3c.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 4 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join AMLODIPINE BESYLATE AMLODIPINE BESYLATE Legacy Pharmaceutical Packaging, LLC 215ef2cb-d5b6-43d5-bbd5-195ec57cde2b 2026-03-03 Warnings, Adverse reactions Exact identifier application applno (ANDA): 078552 application number: ANDA078552 AMLODIPINE BESYLATE AMLODIPINE BESYLATE Epic Pharma, LLC 090f3e51-8129-4b5d-97f9-ab410e14df2d 2025-12-17 Warnings, Adverse reactions Exact identifier application applno (ANDA): 078552 application number: ANDA078552 AMLODIPINE BESYLATE AMLODIPINE BESYLATE Aphena Pharma Solutions - Tennessee, LLC d17ef907-7719-4246-8ade-b67afdfaf787 2024-03-26 Warnings, Adverse reactions Exact identifier application applno (ANDA): 078552 application number: ANDA078552 AMLODIPINE BESYLATE AMLODIPINE BESYLATE Aphena Pharma Solutions - Tennessee, LLC 186b6149-9610-4380-9bf2-941646069276 2023-05-04 Warnings, Adverse reactions Exact identifier application applno (ANDA): 078552 application number: ANDA078552
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 53808-1100-1 53808110001 30 TABLET in 1 BLISTER PACK (53808-1100-1) 30 tablet 2018-01-23 0000-00-00 No No Current